Korea, Democratic People's Republic of vs Malaysia: Hypertension treatment coverage among adults aged 30-79 with
Korea, Democratic People's Republic of
43.0%
in 2019
Malaysia
42.9%
in 2019
Korea, Democratic People's Republic of rank
94th
Malaysia rank
95th
Hypertension treatment coverage among adults aged 30-79 with over time
- Korea, Democratic People's Republic of
- Malaysia
How they compare
Korea, Democratic People's Republic of currently reports 43.0% against 42.9% in Malaysia, a difference of 0.1%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Malaysia ahead.
Korea, Democratic People's Republic of ranks 94th and Malaysia ranks 95th of 193 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Korea, Democratic People's Republic of | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 21.1% | 23.5% | 2.4% | Malaysia |
| 2000s | 33.1% | 34.3% | 1.1% | Malaysia |
| 2010s | 41.6% | 41.6% | 0.0% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension treatment coverage among adults aged 30-79 with, Korea, Democratic People's Republic of or Malaysia?
- Korea, Democratic People's Republic of, at 43.0% against 42.9% in Malaysia as of 2019.
- What is the difference in hypertension treatment coverage among adults aged 30-79 with between Korea, Democratic People's Republic of and Malaysia?
- 0.1%, with Korea, Democratic People's Republic of ahead.
- How many years of comparable data are there for Korea, Democratic People's Republic of and Malaysia?
- 30 years are reported by both, from 1990 to 2019.
- How do Korea, Democratic People's Republic of and Malaysia rank globally for hypertension treatment coverage among adults aged 30-79 with?
- Korea, Democratic People's Republic of ranks 94th and Malaysia ranks 95th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension treatment coverage among adults aged 30-79 with hypertension, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.